Researchers believe that they have found a way to help those with celiac disease.

A study conducted in the Gastroenterology journal found that the gluten-specific enzyme ALV003 reduced a patient's exposure to gluten better than a placebo.

While most people don't seem to know what gluten really is , you've probably seen it linked to Celiac Disease, a digestive disease that damages the intestine when consuming gluten.

Researchers hope the ALV003 enzyme can lead to a pill that aids gluten-intolerant folks. Even with a gluten-free diet, there is still potential harm being done to the intestines through accidental gluten consumption. Theoretically, the pill would reduce the harm done by the sneaky protein composite.

In the study, researchers randomly selected 41 people in Finland diagnosed with celiac disease to take either ALV003 or a placebo pill every day. They then asked them to eat 2 grams of gluten daily for 6 weeks and took samples of the small intestine to analyze. Daniel Adelman, the lead researcher found that the those who took the placebo pill had a notably higher amount of intestinal injuries and inflammation than those who took the ALV003 pill. There a was no visible change in the intestines of the subjects who took ALV003, suggesting the pill protected them from  harm.

However, this doesn't mean celiacs should head to the pastry aisle just yet. "This drug is not intended to allow you to go have a pizza or French bread," Adelman told HuffPo. "It's not intended to replace the gluten-free diet -- just allow it to be more effective, we hope."